RENO, Nev.--(BUSINESS WIRE)--Lifeline Biotechnologies, Inc. (Pink Sheets: LLBO) today reported the regulatory strategy for its First Warning System™ is well underway and the development of an FDA submission for a 510(k) marketing clearance is expected to be filed later this year.
